Table III.
Summary of the clinical characteristics of patients in groups A and B.
| Group | Median age, years (CI) | Median preoperative KPS score (CI) | Median postoperative KPS (CI) | Median PFS, months (CI) | Median OS, months (CI) | Mean tumor size, mm (CI) | Proportion of tumor in dominant side, % | Lobular localization, n |
|---|---|---|---|---|---|---|---|---|
| Group A | 61 (57.97–63.28) | 76.16 (72.59–79.74) | 80.68 (77.82–83.53) | 5.5 (3.79–7.21) | 9.0 (8.14–9.86) | 45.7 (41.97–49.43) | 48.6 | Frontal, 22; temporal, 24; parietal, 3; occipital, 3; multilobular, 22 |
| Group B | 58.5 (53.27–59.20) | 81.05 (76.63–85.47) | 84.74 (81.60–87.87) | 8.5 (4.36–12.64) | 27.0 (22.17–31.83) | 49.16 (44.46–53.86) | 49.1 | Frontal, 18; temporal, 12; parietal, 4; occipital, 4; multilobular, 20 |
| P-value | 0.0293 | 0.0883 | 0.0579 | 0.007 | <0.0001 | 0.2490 | 0.9500 | 0.6701 |
Group A, OS <24 months; group B, OS >24 months; PFS, profession-free survival; CI, confidence interval; OS, overall survival; KPS, Karnofsky performance status.